We are open with limited hours and staff.
Price range: $209.00 through $807.00
Lortab 10/325mg refers to a hydrocodone bitartrate and acetaminophen combination containing 10mg of hydrocodone bitartrate and 325mg of acetaminophen per tablet. Hydrocodone is an opioid analgesic, while acetaminophen provides additional pain-relieving and fever-reducing effects.
This medication may be prescribed when pain requires opioid treatment and other options do not provide adequate relief. However, treatment should always be individualized. Healthcare professionals consider factors such as pain severity, previous opioid exposure, treatment response, and the potential for misuse or dependence.
Because hydrocodone affects the central nervous system, it can cause drowsiness, dizziness, constipation, sedation, and potentially dangerous respiratory depression. Therefore, patients should follow their prescribed instructions carefully and avoid changing the dose without professional guidance.
Safety remains especially important with opioid-containing medicines. Alcohol, benzodiazepines, sedatives, and other central nervous system depressants can increase the risk of profound sedation and breathing problems. Consequently, patients should discuss all prescription medicines, over-the-counter products, supplements, and alcohol use with their healthcare provider.
The acetaminophen component also requires attention. Excessive acetaminophen exposure can cause serious liver injury, particularly when multiple acetaminophen-containing products are combined. For this reason, patients should check medication labels and follow professional guidance regarding total daily exposure.
Possible adverse effects include nausea, vomiting, dizziness, drowsiness, constipation, and sedation. Slow, shallow, or difficult breathing, extreme sleepiness, or an inability to wake requires immediate medical attention.
Lortab 10/325mg should be used only as prescribed. Patients should never share prescription opioids with another person, even if that person experiences similar symptoms. Secure storage also helps reduce accidental exposure, misuse, and theft.
Current labeling recommends using the lowest effective dose and adjusting treatment according to the individual patient’s response. In addition, patients who have developed physical dependence should not stop regular opioid treatment abruptly. A healthcare professional can provide an appropriate gradual reduction plan when treatment ends.
Finally, patients should discuss breathing conditions, liver problems, pregnancy, other medications, alcohol use, and any history of substance misuse with their healthcare provider. Naloxone may also be considered when there is a risk of accidental opioid exposure or overdose.
This page provides general medication information and does not replace advice from a licensed healthcare professional. Product names, manufacturers, formulations, and labeling can vary, so the actual medication label should always be verified.
SEO note: Exact 10% passive voice and 30% transition-word usage cannot be guaranteed across SEO analyzers because each tool uses different counting rules. This copy is optimized toward those targets while keeping keyword density low and readability natural.
